Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cats develop dementia similarly to humans, study finds
"Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals" - Dr Robert McGeachan.

Researchers have described the finding as ‘the perfect natural model for Alzheimer’s’.

New research suggests cats develop dementia in a similar way to people with Alzheimer’s disease.

The study by the University Edinburgh discovered a build-up of the toxic protein amyloid-beta in the brains of cats with the condition — one of the defining features of Alzheimer’s disease.

Experts say their findings reveal how amyloid-beta could lead to age-related brain dysfunction and memory loss in cats. 

Study lead Dr Robert McGeachan, from the University of Edinburgh’s Royal (Dick) School of Veterinary Studies, said: “Dementia is a devastating disease - whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer’s disease in people. 

“This opens the door to exploring whether promising new treatments for human Alzheimer’s disease could also help our ageing pets. Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.”

In the study, scientists examined the brains of 25 cats of different ages who had passed away, including some that had signs of dementia. Powerful microscopic imaged revealed a build-up of amyloid-beta within the synapses of older cats and cats with dementia.

Until now, the study of Alzheimers disease has largely relied on genetically-modified rodent models, who do not naturally develop dementia. Scientists say studying cats with dementia could help advance knowledge and aid in the development of treatments for both cats and humans. 

Professor Danièlle Gunn-Moore, personal chair of feline medicine at the Royal (Dick) School of Veterinary Studies, said: “Feline dementia is so distressing for the cat and for its person. It is by undertaking studies like this that we will understand how best to treat them. 

“This will be wonderful for the cats, their owners, people with Alzheimer’s and their loved ones. Feline dementia is the perfect natural model for Alzheimer’s, everyone benefits.”

The study, Amyloid-Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome: A Naturally Occurring Model of Alzheimer's Disease, is published in the European Journal of Neuroscience

Image (C) Shutterstock.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.